N/A
Completed N=2,057
The Tobacco, Alcohol, Prescription Medication and Other Substances Tool
Source: ClinicalTrials.gov NCT02110693 ↗Enrolled (actual)
2,057
Serious AEs
0.0%
Results posted
Apr 2018
Primary outcomePrimary: Diagnostic and Statistical Manual-5 (DSM-5) Alcohol Use Disorder Diagnosis Measured by the Modified World Mental Health Composite International Diagnostic Interview — .70; .74 Sensitivity
Summary
The purpose of the study is to develop and validate a questionnaire to screen and assess adult primary care patients for tobacco, alcohol, prescription drug, and drug use and problems related to their use.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Diagnostic and Statistical Manual-5 (DSM-5) Alcohol Use Disorder Diagnosis Measured by the Modified World Mental Health Composite International Diagnostic Interview |
.70; .74 | — |
| PRIMARY Diagnostic and Statistical Manual-5 (DSM-5) Cannabis Use Disorder Diagnosis Measured With Modified World Mental Health Composite International Diagnostic Interview |
0.71; .70 | — |
| PRIMARY Diagnostic and Statistical Manual-5 (DSM-5) Cocaine and Amphetamine (Stimulant) Use Disorder Diagnosis Measured by the Modified World Mental Health Composite International Diagnostic Interview |
.57; .60 | — |
| PRIMARY Diagnostic and Statistical Manual DSM-5 Diagnosis of Heroin Use Disorder Measured by the The Modified World Mental Health Composite International Diagnostic Interview |
.66; .66 | — |
| PRIMARY Diagnostic and Statistical Manual DSM-5 Diagnosis of Tobacco Use Disorder Measured by the Modified World Mental Health Composite International Diagnostic Interview |
.74; .73 | — |
| SECONDARY High Risk Tobacco Use Measured by the Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) |
.90; .90 | — |
| SECONDARY Unhealthy Cannabis Use |
.85; .84 | — |
| SECONDARY Risky Alcohol Use |
.63; .64 | — |
| SECONDARY Cigarette Smoking Risk |
.73; .75 | — |
| SECONDARY Smokeless Tobacco Questionnaire |
.29; .28 | — |
| SECONDARY Cannabis Positive Oral Fluid Test |
.42; .40 | — |
Eligibility Criteria
Inclusion Criteria
- Primary care patients
- Able to provide informed consent
Exclusion Criteria
- inability to comprehend spoken English
- inability to self-administer the instrument on the tablet computer due to physical limitations
- previously enrolled in the study
Data sourced from ClinicalTrials.gov (NCT02110693). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.